Methods of prevention of oral mucositis with transforming growth factor .beta.
US5635489A · kind A · utility
15Cited by
6References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 28, 1995 |
| Grant date | Jun 3, 1997 |
| Priority date | — |
| Expiry date | Feb 28, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/1841
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of preventing oral mucositis in a subject susceptible to mucositis which comprises administering to the subject a prophylactically effective amount of TGF-.beta.3. Typically, administration is topical and initiated prior to anti-neoplastic therapy such as radiation treatment or chemotherapy. The invention is particularly suited for pediatric patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.